Can mayonnaise cure my infertility?

A controversial treatment that has divided medical professionals is offering hope to women who have suffered multiple miscarriagesIt is a warm spring day, and I am sitting in a private clinic in Surrey with a drip in my arm. I am having an infusion of intralipids, a white emulsion of soybean oil and egg: mayonnaise, basically. On top of that, I am taking a daily dose of steroids. I have signed a form declaring that I am aware intralipids are not licensed for use in pregnancy, and that there is a lack of scientific evidence for their use in my condition; and I know that the steroids have potential side-effects ranging from psychosis to liver failure. Yet here I am, watching the mayonnaise make its way into my bloodstream, hoping this unproven treatment will protect the tiny twins I am carrying.After years of infertility and a miscarriage, I have decided to put my faith in reproductive immunology, a field of medicine that is either fantastically promising or utterly bogus, depending on whom you ask. Its critics see the treatments as bad medicine, and a cash cow for private fertility clinics. Its advocates, including women who finally have a healthy baby after four or five losses, think it could revolutionise the way we think about pregnancy. As for me, I feel I have nothing to lose. At the NHS hospital where I miscarried at the beginning of this year, I was told there was nothing I could do but go away and try again.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Fertility problems Family Health Society Life and style Source Type: news

Related Links:

Abstract OBJECTIVE: To ascertain whether stress biomarker and psychological indices of stress may predict both conception and miscarriage rates in women undergoing in-vitro fertilization/ intracytoplasmic sperm injection (IVF/ ICSI). DESIGN: Prospective observational study. SETTING: A university-affiliated tertiary hospital. POPULATION OR SAMPLE: Infertility women who were undergoing fresh or frozen IVF/ICSI cycles. METHODS: Subjects were recruited to (1) completed validated psychological questionnaires (visual analogue scale of stress, state trait anxiety inventory, perceived stress scale, fer...
Source: BJOG : An International Journal of Obstetrics and Gynaecology - Category: OBGYN Authors: Tags: BJOG Source Type: research
Abstract BACKGROUND: Pregnancies following assisted reproductive technology (ART) may have elevated potential risk of pregnancy loss (PL) when compared to natural conception. However, rare studies comprehensively analyzed the IVF/ICSI cycle-dependent factors for loss of clinical pregnancy. Therefore, we aimed to determine the ART subgroup-specific risks of PL throughout pregnancy and explore different risk factors for early miscarriage and late miscarriage among pregnancies conceived through ART. METHODS: A retrospective cohort study was launched in two infertility treatment centers in Nanjing and Changzhou i...
Source: Reproductive Biology - Category: Reproduction Medicine Authors: Tags: Reprod Biol Endocrinol Source Type: research
AbstractAsherman ’s Syndrome (AS) is an acquired condition defined by the presence of intrauterine adhesions (IUA) that cause symptoms such as menstrual abnormalities, pelvic pain, infertility, recurrent miscarriage, abnormal placentation and attendant psychological distress. Classically, AS is considered an iatro genic disease triggered by trauma to the pregnant uterus. Different factors can cause the destruction of the endometrium, thus affecting the endometrial stem cell niche and creating IUAs. Curettage of the pregnant uterus appears to be the most common source of this destruction. Nevertheless, some AS cases h...
Source: Human Reproduction - Category: Reproduction Medicine Source Type: research
Celiac disease (CD) is a disorder characterized by an autoimmune reaction triggered by sensitivity to gluten, the protein component of wheat, barley, and rye. Celiac disease is present in approximately 1% –2% of the general population, and existing studies have postulated a potential effect on duration of reproductive years, fertility, and pregnancy outcomes. There have been multiple meta-analyses of cohort studies and case–control studies that attempt to elucidate the association between reprodu ctive disorders and incidence of CD (1, 2); these studies found associations between unexplained infertility, recurr...
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: Tags: Reflections Source Type: research
​BY GREGORY TAYLOR, DO, &JACKLYN MCPARLANE​, DOA 31-year-old woman with a significant medical history for one ectopic pregnancy and five spontaneous abortions presented with abdominal pain and vaginal bleeding. Her symptoms started abruptly two days earlier, and the pain was located in the right lower quadrant, which had become diffuse and she described as sharp. She was also experiencing nausea, vomiting, and vaginal bleeding.She stated she had been spotting for five days and soaking up to four pads a day. Her last menstrual period was two months before, and a home pregnancy test was positive. Her presentation was...
Source: The Case Files - Category: Emergency Medicine Tags: Blog Posts Source Type: research
ConclusionFindings revealed an improvement in pregnancy rates following hCG administration in FET cycles.
Source: Middle East Fertility Society Journal - Category: Reproduction Medicine Source Type: research
Publication date: Available online 6 January 2018Source: Middle East Fertility Society JournalAuthor(s): Kamal M. Zahran, Waleed A. Mostafa, Ahmed M. Abbas, Mansour A. Khalifa, Gamal H. SayedAbstractObjectiveTo compare the effect of adjunctive use of cabergoline with clomiphene citrate (CC) in infertile polycystic ovarian syndrome (PCOS) patients with normal prolactin level.Study designA randomized clinical trial (NCT 02644304).SettingAssiut University Hospital, Assiut, Egypt.Materials and methodsInfertile euprolactinemic PCOS patient were recruited and randomized in a 1:1 ratio to CC plus cabergoline or CC alone. All pati...
Source: Middle East Fertility Society Journal - Category: Reproduction Medicine Source Type: research
Publication date: Available online 26 May 2018Source: Middle East Fertility Society JournalAuthor(s): Mervat HariraAbstractBackgroundClomiphene Citrate (CC) considered as first line treatment option for superovulation in patient with unexplained infertility. However, there is discrepancy between ovulation and conception rates.ObjectivesCompare the effect of Clomiphene citrate plus Estradiol Valerate with Letrozole on endometrial thickness, pregnancy and abortion rate in women with unexplained infertility.DesignThis was a randomized double blind study.SettingZagazig University hospitals and a private practice setting.Patien...
Source: Middle East Fertility Society Journal - Category: Reproduction Medicine Source Type: research
CONCLUSIONBecause few studies have investigated fecundity perceptions in their own right, more research is needed to understand how women evaluate their fecundity and to integrate these perceptions into broader frameworks describing women's perception of pregnancy risk. Such work may help identify potential levers to improve contraceptive use.
Source: The Guttmacher Institute - Category: International Medicine & Public Health Authors: Source Type: news
Publication date: September 2018Source: European Journal of Obstetrics &Gynecology and Reproductive Biology, Volume 228Author(s): Li Jie, Deng Li, Chen Yang, Zhang HaiyingAbstractThis systematic review aimed to compare the clinical efficacy of tamoxifen with that of clomiphene citrate (CC) in anovulatory patients. The PubMed, EMBASE, and CNKI databases were searched up to October 2016 for literature comparing tamoxifen with CC in anovulatory women. The pooled risk ratios (RR) or standardized mean differences (SMD) with 95% confidence intervals (CIs) were subjected to statistical analysis. Twelve studies involving 1302 ...
Source: European Journal of Obstetrics and Gynecology and Reproductive Biology - Category: OBGYN Source Type: research
More News: Allergy & Immunology | Babies | Hospitals | Infertility | Liver | Miscarriage | Pregnancy | Reproduction Medicine | Science | Urology & Nephrology | Women